Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Diabetes Care
|
September 22, 2011
Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase
Richard M Bergenstal, William V Tamborlane, Andrew Ahmann, et al.
The Journal of Biological Chemistry
|
November 25, 1990
Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation
K A Lund, C S Lazar, W S Chen, et al.
Gastroenterology
|
September 1, 1987
Occult radiopaque jaw lesions in familial adenomatous polyposis coli and hereditary nonpolyposis colorectal cancer
G J Offerhaus, L S Levin, F M Giardiello, et al.
The New England Journal of Medicine
|
March 12, 1987
Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome
E I Traboulsi, A J Krush, E J Gardner, et al.
Cell
|
October 6, 1989
Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation
W S Chen, C S Lazar, K A Lund, et al.
Diabetes Technology & Therapeutics
|
February 14, 2022
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
Satish K Garg, Mark Kipnes, Kristin Castorino, et al.
Cancer Research
|
October 19, 2001
Molecular classification of human carcinomas by use of gene expression signatures
A I Su, J B Welsh, L M Sapinoso, et al.
The New England Journal of Medicine
|
July 1, 2010
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes
Richard M Bergenstal, William V Tamborlane, Andrew Ahmann, et al.
Genome Research
|
July 4, 2001
Temporal gene regulation during HIV-1 infection of human CD4+ T cells
J Corbeil, D Sheeter, D Genini, et al.
The British Journal of Dermatology
|
October 10, 2013
The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease
A Tjokrowidjaja, B S Daniel, J W Frew, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Diabetes Care
|
September 22, 2011
Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase
Richard M Bergenstal, William V Tamborlane, Andrew Ahmann, et al.
The Journal of Biological Chemistry
|
November 25, 1990
Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation
K A Lund, C S Lazar, W S Chen, et al.
Gastroenterology
|
September 1, 1987
Occult radiopaque jaw lesions in familial adenomatous polyposis coli and hereditary nonpolyposis colorectal cancer
G J Offerhaus, L S Levin, F M Giardiello, et al.
The New England Journal of Medicine
|
March 12, 1987
Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome
E I Traboulsi, A J Krush, E J Gardner, et al.
Cell
|
October 6, 1989
Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation
W S Chen, C S Lazar, K A Lund, et al.
Diabetes Technology & Therapeutics
|
February 14, 2022
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
Satish K Garg, Mark Kipnes, Kristin Castorino, et al.
Cancer Research
|
October 19, 2001
Molecular classification of human carcinomas by use of gene expression signatures
A I Su, J B Welsh, L M Sapinoso, et al.
The New England Journal of Medicine
|
July 1, 2010
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes
Richard M Bergenstal, William V Tamborlane, Andrew Ahmann, et al.
Genome Research
|
July 4, 2001
Temporal gene regulation during HIV-1 infection of human CD4+ T cells
J Corbeil, D Sheeter, D Genini, et al.
The British Journal of Dermatology
|
October 10, 2013
The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease
A Tjokrowidjaja, B S Daniel, J W Frew, et al.
Page
of 12